If memory loss, confusion, inability to solve issues, or inability to make choices are becoming a problem in daily life, then someone has dementia. It is not a particular sickness, but rather a general word. According to the Alzheimer’s Association, 6 million Americans suffer with Alzheimer’s disease, which is the most prevalent form of dementia.
Even though it predominantly affects those over the age of 65, it is not a typical symptom of aging. Dementia will affect roughly 14 million Americans by the year 2060, according to the Centers for Disease Control and Prevention (CDC).
As we age, dementia affects our thinking and actions, making it one of the most common causes of impairment and reliance. Suppose, however, that you could halt the progression of this degenerative condition.
New study shows link between dementia and vitamin D deficiency
Dementia and vitamin D deficiency have been linked by new genetic research from the University of South Australia, which is a world-first study. According to the findings of this research, which looked at the relationship between vitamin D, brain imaging characteristics, and the risk of dementia and stroke:
Vitamin D deficiency has been linked to shrinkage of the brain’s volume and an increased risk of cognitive decline and a stroke. Vitamin D insufficiency is linked to dementia, according to genetic studies. Some communities may be able to prevent up to 17% of dementia cases by raising everyone’s vitamin D levels to normal levels (50 nmol/L).
Alzheimer’s disease, often known as Alzheimer’s disease or dementia, is a degenerative brain disease that worsens with time. Dementia is the second greatest cause of mortality in Australia, affecting an estimated 487,500 people. As many as 55 million individuals worldwide suffer from Alzheimer’s disease, with an estimated 10 million new cases identified each year.
Insufficient levels of vitamin D (25 nmol/L) have been linked to an increased risk of Alzheimer’s disease and stroke in a genetic analysis that assessed data from 294,514 persons in the UK Biobank. Neuroimaging results, dementia, and stroke all had their underlying causality tested by nonlinear Mendelian randomization (MR), a technique that uses measurable variation in genes in order to determine the cause of a modifiable exposure.
